Your browser doesn't support javascript.
loading
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.
O'Donnell, Peter H; Milowsky, Matthew I; Petrylak, Daniel P; Hoimes, Christopher J; Flaig, Thomas W; Mar, Nataliya; Moon, Helen H; Friedlander, Terence W; McKay, Rana R; Bilen, Mehmet A; Srinivas, Sandy; Burgess, Earle F; Ramamurthy, Chethan; George, Saby; Geynisman, Daniel M; Bracarda, Sergio; Borchiellini, Delphine; Geoffrois, Lionnel; Maroto Rey, Jose Pablo; Ferrario, Christiano; Carret, Anne-Sophie; Yu, Yao; Guseva, Maria; Homet Moreno, Blanca; Rosenberg, Jonathan E.
Afiliación
  • O'Donnell PH; University of Chicago, Chicago, IL.
  • Milowsky MI; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
  • Petrylak DP; Yale Cancer Center, New Haven, CT.
  • Hoimes CJ; Duke Cancer Institute, Duke University, Durham, NC.
  • Flaig TW; University of Colorado Comprehensive Cancer Center, Aurora, CO.
  • Mar N; University of California at Irvine, Irvine, CA.
  • Moon HH; Kaiser Permanente Southern California, Riverside, CA.
  • Friedlander TW; University of California at San Francisco, San Francisco, CA.
  • McKay RR; University of California at San Diego, San Diego, CA.
  • Bilen MA; Emory University Winship Cancer Institute, Atlanta, GA.
  • Srinivas S; Stanford Cancer Center, Stanford, CA.
  • Burgess EF; Levine Cancer Center, Charlotte, NC.
  • Ramamurthy C; University of Texas Health Sciences Center at San Antonio, San Antonio, TX.
  • George S; Roswell Park Cancer Center, Buffalo, NY.
  • Geynisman DM; Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA.
  • Bracarda S; Azienda Ospedaliera Santa Maria di Terni, Terni, Italy.
  • Borchiellini D; Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
  • Geoffrois L; Institut de Cancerologie de Lorraine, Vandoeuvre Les Nancy, France.
  • Maroto Rey JP; Hospital de la Santa Creu i Sant Paul, Barcelona, Spain.
  • Ferrario C; Jewish General Hospital, Montreal, Quebec, Canada.
  • Carret AS; Seagen Inc, Bothell, WA.
  • Yu Y; Seagen Inc, Bothell, WA.
  • Guseva M; Astellas Pharma, Northbrook, IL.
  • Homet Moreno B; Merck & Co Inc, Rahway, NJ.
  • Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, NY.
J Clin Oncol ; 41(25): 4107-4117, 2023 09 01.
Article en En | MEDLINE | ID: mdl-37369081
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales / Cisplatino Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Israel
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales / Cisplatino Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Israel